| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head, Translational Research
1 company
Winquist Raymond is a Head, Translational Research at Xenon Pharmaceuticals Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $55K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2017 | XENE Xenon Pharmaceuticals Inc. | Head, Translational Research | Buy | 1,000 | $3.00 | $2,995.00 | New |